Industry Overview - The cannabis sector has experienced a steady decline, but there are indications that the future for marijuana stocks could improve [1] - Many companies are showing success and profitability, yet this has not significantly impacted the public sector [1] - The industry is awaiting federal reforms, such as rescheduling or banking reform, to create a more efficient and compliant market [2] Market Potential - Almost every state in the US has legalized cannabis, along with several global regions, indicating a growing market [2] - Canada is also a significant market, and there is a positive outlook for potential gains in the cannabis sector [3] Company Highlights - **Trulieve Cannabis Corp.**: Operates as a cannabis retailer, cultivating, processing, and distributing cannabis products. The company has filed a shelf registration statement with the SEC [4][6] - **Green Thumb Industries Inc.**: Manufactures and sells cannabis products for medical and adult use in the US, operating through Retail and Consumer Packaged Goods segments [6] Upcoming Events - Trulieve will hold a Q2 2024 conference call on August 6 to discuss its results [6] - Green Thumb Industries will release its second quarter 2025 financial results after the market closes on August 6, 2025, followed by a conference call [9]

Core Insights - Planet 13 Holdings Inc. has relaunched its loyalty program, which includes a price match guarantee for any third-party advertised price, enhancing its position as a leading cannabis retailer [1][4]. Loyalty Program Highlights - The loyalty program is designed to provide customers with unbeatable value and world-class experiences, emphasizing that loyalty extends beyond discounts [2][4]. - Customers can enroll for free in-store or online, allowing immediate access to savings and VIP event access [4]. - A 50% discount is available for all loyalty members in Nevada, with easy qualification by spending $100 or more [7]. Upcoming Events and Experiences - Planet 13 is focusing on customer appreciation through events such as "Planet the 13 Day," which will feature product launches and giveaways, and "Retrograde Day," promising unique surprises [7]. - The company aims to create consistently elevated experiences for its customers, including concerts and cultural events [4]. Company Overview - Planet 13 is a vertically integrated cannabis company with operations in California, Nevada, Illinois, and Florida, and is known for having the largest dispensary in the U.S. located in Las Vegas [5]. - The company operates 37 dispensaries nationwide and is focused on building a recognizable global brand in the cannabis industry [5].

Core Viewpoint - AYR Wellness Inc. has entered into an amendment to its Limited Waiver Agreement with the majority holders of its senior secured notes, extending the temporary waiver period to July 18, 2025, to facilitate ongoing negotiations and explore strategic options to strengthen its capital structure [1][3]. Group 1: Limited Waiver Agreement - The Majority Holders have provided a waiver for certain events of default related to AYR's delay in filing interim financial statements for Q1 2025 and specific payment defaults under other outstanding indebtedness [2]. - The extension does not permanently waive existing defaults or rights under governing documents but allows for continued dialogue and exploration of strategies to address financial obligations [3]. Group 2: Business Operations - AYR Wellness continues to operate its business in the ordinary course and is evaluating growth opportunities in key markets [4]. - The company operates as a vertically integrated cannabis business with over 90 licensed dispensaries and a range of cannabis consumer packaged goods brands [6].

Market Overview - The Legal Cannabis Market has grown from USD 33.52 billion in 2024 to USD 42.91 billion in 2025, with a projected value of USD 144.18 billion by 2030, reflecting a compound annual growth rate (CAGR) of 27.52% [2][11]. - The market evolution is driven by legislative changes, consumer behavior, and technological advancements [2]. Industry Dynamics - Legislative changes and increasing consumer acceptance have led to a diverse range of products, including extracts and edibles, while regulatory bodies are enhancing quality control measures [3]. - Vertical integration and partnerships are essential for achieving scale and distribution advantages, with advances in cultivation improving yields and consistency [4]. - Federal developments are fostering optimism regarding interstate commerce and harmonized licensing and taxation frameworks [5]. Investment Trends - There is a noticeable shift towards ancillary services and strategic mergers and acquisitions, which are reshaping competitive landscapes and refining value creation across the supply chain [6]. - Decision-makers are gaining strategic insights to identify opportunities amid evolving consumer preferences and technological advancements [6]. Tariff Impact - New tariff structures in 2025 have increased costs for cultivation and processing, leading to reassessments of manufacturing locations and supplier networks [8]. - Retailers are facing margin pressures due to increased duties on imported machinery and packaging components, often passing costs to consumers [9]. - Regional operators are diversifying sourcing strategies to mitigate future tariff effects, fostering collaborative partnerships to maintain resilience [9]. Key Report Attributes - The report spans 193 pages, covering the forecast period from 2025 to 2030, with an estimated market value of USD 42.91 billion in 2025 and a forecasted value of USD 144.18 billion by 2030 [11].

Core Insights - Cresco Labs (CRLBF) is facing persistent challenges in the U.S. cannabis market despite being a leading vertically integrated operator [1][2] - The company reported a 10% year-over-year decline in revenues for Q1 2025, totaling $165.8 million, amid restrictive federal laws and fragmented state regulations [3][9] - Adjusted gross margin decreased to 49.3%, down 220 basis points year-over-year, while adjusted EBITDA margins contracted to nearly 22% from 28.8% [4][9] - The company anticipates further revenue pressure in Q2 due to a mandatory system transition in Illinois, despite ongoing expansion efforts [5][9] - Cresco's stock has declined 24% year-to-date, contrasting with a 6% rise in the industry [8] Company Performance - Cresco's revenues are solely generated from the U.S., making it vulnerable to domestic market challenges [2] - The company generated $30 million in operating cash flow, but profitability is under pressure from rising costs [4] - Loss estimates for 2026 and 2027 have widened over the past 60 days, indicating ongoing financial difficulties [11] Competitive Landscape - Cresco faces stiff competition from peers like Aurora Cannabis, Canopy Growth, and Tilray Brands, which are also pursuing expansion and cost-optimization strategies [6] - Competitors are diversifying their revenue streams internationally, giving them an edge over Cresco, which remains reliant on the saturated U.S. market [7] Future Outlook - The company's turnaround is contingent on a broader regulatory shift in the U.S., which remains uncertain in the near term [12] - Despite operational discipline and free cash flow generation, the stock is considered to have limited upside and elevated risk for conservative investors [12]

TORONTO and GLIL YAM, Israel, July 11, 2025 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce the filing and effectiveness of a shelf registration statement (the "Shelf Registration") on Form F-3 with the Securities and Exchange Commission ("SEC").The Shelf Registration will allow the Company to offer and sell, from time to time, up to an aggregate of $50 million of its common shares, wa ...

Buying shares of beaten-down companies only makes sense if there are good reasons to expect them to bounce back. If that's not the case, stocks that may look cheap and attractive aren't actually so. You should be careful to avoid catching falling knives.Let's consider two stocks that have significantly lagged the market in recent years but could still fall further: Canopy Growth (CGC -5.95%) and Novavax (NVAX 0.92%). 1. Canopy GrowthCanopy Growth emerged as a leader in the cannabis industry toward the end o ...

VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis, is pleased to announce that it will hold its Annual General and Special Meeting (the “Meeting”) of shareholders at 10:00 AM PT on July 31, 2025 in person at the Terminal City Club, 837 West Hastings Street, Vancouver, British Columbia, V6C 1B6, for the following pu ...

Top Cannabis Real Estate Stocks for July 2025: REITs with Strong UpsideCannabis REITs are gaining momentum this week as investors seek dividend-paying stocks with long-term growth potential. These companies lease properties to licensed cannabis operators, generating steady income for their shareholders. As the cannabis sector matures, real estate investment trusts provide stability and consistent payouts. The U.S. cannabis market is projected to reach over $45 billion by the end of 2025. Annual growth rates ...

Core Viewpoint - TerrAscend Corp. will host a conference call to discuss its second quarter financial results for 2025 on August 7, 2025, after market close [1] Group 1: Conference Call Details - The conference call is scheduled for Thursday, August 7, 2025, at 5:00 p.m. Eastern Time [2] - A webcast will be available at https://app.webinar.net/0K9b289Jyd7 [2] - The dial-in number for the call is 1-888-510-2154, with a replay available until midnight Eastern Time on August 21, 2025 [2] Group 2: Company Overview - TerrAscend is a leading cannabis company listed on TSX, with operations across North America, including states like Pennsylvania, New Jersey, Maryland, Ohio, Michigan, and California [3] - The company operates retail locations such as The Apothecarium and Gage, along with cultivation, processing, and manufacturing facilities [3] - TerrAscend offers a wide range of high-quality cannabis products for both medical and legal adult-use markets, owning or licensing several brands including Gage Cannabis, Cookies, and Wana [3]